Cardiovascular Effects of Angiotensin (1-7) in Essential Hypertension

Clinical trial NCT02245230 · TERMINATED

Trial details

NCT number: NCT02245230
Sponsor: Vanderbilt University
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Hypertension Hypertension, Essential

Start date: 2015-01-01
Primary completion: 2023-12-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.